These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8305326)
1. Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides. Hill VA; Whittaker SJ; Hunt BJ; Liddell K; Spittle MF; Smith NP Br J Dermatol; 1994 Jan; 130(1):92-6. PubMed ID: 8305326 [TBL] [Abstract][Full Text] [Related]
2. Mycosis fungoides masquerading as cutaneous lupus erythematosus and associated with antiphospholipid syndrome. Veysey EC; Wilkinson JD Clin Exp Dermatol; 2008 Jan; 33(1):26-9. PubMed ID: 17979989 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous manifestations in antiphospholipid syndrome. Caporuscio S; Sorgi ML; Nisticò S; Pranteda G; Bottoni U; Carboni I; Del Duca E; Pranteda G Int J Immunopathol Pharmacol; 2015 Jun; 28(2):270-3. PubMed ID: 25875603 [TBL] [Abstract][Full Text] [Related]
4. Widespread cutaneous necrosis occurring in association with the antiphospholipid syndrome: a report of two cases. Creamer D; Hunt BJ; Black MM Br J Dermatol; 2000 Jun; 142(6):1199-203. PubMed ID: 10848747 [TBL] [Abstract][Full Text] [Related]
5. Hodgkin's lymphoma arising in a case of mycosis fungoides: An unusual association. Sharma P; Goyal S; Yadav AK; Singh J; Mandal AK Indian J Dermatol Venereol Leprol; 2018; 84(3):292-297. PubMed ID: 29098990 [TBL] [Abstract][Full Text] [Related]
6. PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread. Roupe G; Sandström MH; Kjellström C Acta Derm Venereol; 1996 Nov; 76(6):475-8. PubMed ID: 8982416 [TBL] [Abstract][Full Text] [Related]
7. [Change of level of mycosis fungoides under systemic PUVA-therapy (author's transl)]. Tourbier H; Schultz-Ehrenburg U Z Hautkr; 1981 Jul; 56(14):923-9. PubMed ID: 7269717 [TBL] [Abstract][Full Text] [Related]
8. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA. Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078 [TBL] [Abstract][Full Text] [Related]
13. [Hypopigmented mycosis fungoides]. Robert C; Bahlouli Z; Chemaly P; Flageul B; Blanchet-Bardon C; Dubertret L Ann Dermatol Venereol; 1995; 122(10):704-6. PubMed ID: 8687060 [TBL] [Abstract][Full Text] [Related]
14. Bcl-2 expression in mycosis fungoides before and after PUVA therapy. Weshahy H; Mahgoub D; El-Eishy N; El-Tawdy AM; Bassiouny DA; Hunter N; Hindawi A Photodermatol Photoimmunol Photomed; 2010 Apr; 26(2):107-9. PubMed ID: 20415745 [TBL] [Abstract][Full Text] [Related]
15. Mycosis fungoides associated with B-cell malignancies. Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178 [TBL] [Abstract][Full Text] [Related]
16. [Results of photochemotherapy in a series of 47 patients with mycosis fungoides]. Piccinno R; Caccialanza M; Mainardi L G Ital Dermatol Venereol; 1989; 124(7-8):369-73. PubMed ID: 2628282 [TBL] [Abstract][Full Text] [Related]
17. Necrotizing vasculitis within cutaneous lesions of mycosis fungoides. Granstein RD; Soter NA; Haynes HA J Am Acad Dermatol; 1983 Jul; 9(1):128-33. PubMed ID: 6886095 [TBL] [Abstract][Full Text] [Related]